[{"address1": "Robert Koch Strasse 50", "city": "Mainz", "zip": "55129", "country": "Germany", "phone": "49 6131 554 2860", "website": "https://mainzbiomed.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. Guido  Baechler", "age": 59, "title": "CEO & Executive Director", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Von Toerne P.M.P., Ph.D.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stefan  Erlach", "title": "Head of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.23, "open": 1.23, "dayLow": 1.18, "dayHigh": 1.29, "regularMarketPreviousClose": 1.23, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.18, "regularMarketDayHigh": 1.29, "payoutRatio": 0.0, "beta": 0.275, "forwardPE": -1.6216216, "volume": 400094, "regularMarketVolume": 400094, "averageVolume": 511496, "averageVolume10days": 178590, "averageDailyVolume10Day": 178590, "bid": 1.0, "ask": 1.04, "bidSize": 1, "askSize": 1, "marketCap": 10300728, "fiftyTwoWeekLow": 0.92, "fiftyTwoWeekHigh": 8.2, "allTimeHigh": 30.0, "allTimeLow": 0.18, "priceToSalesTrailing12Months": 15.608701, "fiftyDayAverage": 1.30132, "twoHundredDayAverage": 2.082495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6092761, "profitMargins": 0.0, "floatShares": 4067384, "sharesOutstanding": 8583939, "sharesShort": 310409, "sharesShortPriorMonth": 36944, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.036199998, "heldPercentInsiders": 0.00868, "heldPercentInstitutions": 0.056160003, "shortRatio": 0.38, "shortPercentOfFloat": 0.0364, "impliedSharesOutstanding": 8583940, "bookValue": 0.616, "priceToBook": 1.948052, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -18971112, "trailingEps": -5.28, "forwardEps": -0.74, "enterpriseToRevenue": 9.232, "enterpriseToEbitda": -0.377, "52WeekChange": -0.7520161, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 1.2, "targetHighPrice": 14.0, "targetLowPrice": 14.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1911069, "totalCashPerShare": 0.467, "ebitda": -16145343, "totalDebt": 3093607, "quickRatio": 0.352, "currentRatio": 0.515, "totalRevenue": 659935, "debtToEquity": 122.648, "revenuePerShare": 0.292, "returnOnAssets": -1.14352, "grossProfits": 445434, "freeCashflow": -8186486, "operatingCashflow": -15461421, "revenueGrowth": -0.449, "grossMargins": 0.67497003, "ebitdaMargins": 0.0, "operatingMargins": -28.22059, "financialCurrency": "USD", "symbol": "MYNZ", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Mainz Biomed N.V.", "longName": "Mainz Biomed N.V.", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1766189390, "regularMarketTime": 1766178000, "exchange": "NCM", "messageBoardId": "finmb_1679642292", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "earningsTimestampStart": 1743508955, "earningsTimestampEnd": 1743508955, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.28, "epsForward": -0.74, "twoHundredDayAverageChangePercent": -0.4237681, "fiftyDayAverageChange": -0.10131991, "fiftyDayAverageChangePercent": -0.077859335, "twoHundredDayAverageChange": -0.8824949, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "prevName": "Mainz Biomed B.V.", "nameChangeDate": "2025-12-19", "cryptoTradeable": false, "regularMarketChangePercent": -2.43902, "regularMarketPrice": 1.2, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "postMarketChangePercent": 3.33333, "postMarketPrice": 1.24, "postMarketChange": 0.03999996, "regularMarketChange": -0.03, "regularMarketDayRange": "1.18 - 1.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 511496, "fiftyTwoWeekLowChange": 0.28000003, "fiftyTwoWeekLowChangePercent": 0.30434784, "fiftyTwoWeekRange": "0.92 - 8.2", "fiftyTwoWeekHighChange": -7.0, "fiftyTwoWeekHighChangePercent": -0.85365856, "fiftyTwoWeekChangePercent": -75.201614, "displayName": "Mainz Biomed", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]